Is Galapagos Stock a Bad-News Buy Right Now?
Despite some serious setbacks, this beaten-down biotech could be a terrific bargain at recent prices.
3 Reasons Rigel Pharmaceuticals Stock Can Continue Soaring
Here's why this stock's big run-up in recent months could be just the beginning.
Johnson & Johnson's COVID-19 Vaccine Inventory Is Lighter Than Expected
If authorized for emergency use later this month, the White House expects just a few million doses of Johnson & Johnson's coronavirus vaccine candidate in its inventory by the end of February.
3 Top Healthcare Stocks to Buy Now
Find out how shares of these disruptive businesses could make you rich.
3 Reasons to Buy Ocular Therapeutix Stock Right Now
There are a few reasons this could be the best biotech stock you can buy at the moment.
Is Ocugen a Buy After Doubling Last Week?
This company's coronavirus vaccine partner took some big steps forward.
Gilead Sciences and Galapagos Shutter Their Pulmonary Fibrosis Program
Despite solid signs of efficacy in mid-stage trials, the partners are shutting down all clinical trials with ziritaxestat.
Can KalVista Pharmaceuticals Stock Fly Higher?
Can this under-the-radar biotech and its hereditary angioedema candidate produce more gains for investors?
Should You Sell Cassava Sciences Stock Now?
Can this company's Alzheimer's disease candidate deliver further gains ahead?
Here's Why Investors Should Remember These 2 Healthcare Lessons in 2021
If you're thinking about investing in healthcare stocks this year, remember these two things.
The Scariest Part of Intuitive Surgical's Latest Earnings Call
Here's why shares of the surgical robotics company have been under pressure.
1 Big Problem in Johnson & Johnson's Latest Earnings Call
The coronavirus pandemic continues to pressure one of the company's big operating segments.
2 Green Flags for Abbott Labs and 1 Red Flag
Coronavirus testing won't last forever, but the future still looks bright for Abbott Labs.
Is Abbott Labs a Good Stock to Buy Now?
Luckily, coronavirus tests aren't this company's only rising source of revenue.
2 Green Flags in Intuitive Surgical's Q4 Earnings
Despite a tough year, there were two big sources of encouragement from the surgical robotics leader.
2 Green Flags in Johnson & Johnson's Latest Earnings Report
Strong pharmaceutical sales and an impressive growth forecast gave investors reasons to smile.
Here's Why Novavax Can Beat Johnson & Johnson in the COVID-19 Vaccine Race
Johnson & Johnson's coronavirus vaccine offers one-shot convenience, but Novavax has clear advantages.
Here's Why Pfizer's a Great Stock to Buy and Hold Now
Around $15 billion from coronavirus vaccine sales this year will be just the beginning.
5 Reasons to Buy Clover Health Stock Right Now
After decades of effort, electronic health records could finally get an upgrade that allows them to work as intended.
Coronavirus Vaccine From Novavax Is 89.3% Effective
Results of a U.K. study suggest that an easy-to-distribute COVID-19 vaccine from Novavax is effective against the new variant.